FWBI stock gains as IND amendment for adrulipase is under FDA review (NASDAQ:FWBI)
JHVEPhoto Nano-cap biotech First Wave BioPharma (NASDAQ:FWBI) announced that its Investigational New Drug (IND) amendment for ...
Read moreTag: FWBI
Get the latest news and follow the coverage of Financial News, Stocks, Analysis, Trading Updates and more from the top trusted sources.